Supernus Pharmaceuticals Inc (SUPN)
Depreciation & Amortization
$25.75M
Quarterly · Period ending: · USD
SUPN Depreciation & Amortization
Latest reported$25.75Mperiod ending
Latest reported$25.75Mperiod ending
SUPN Quarterly Depreciation & Amortization ($282.40K → $25.75M)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
SUPN depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 25,747,000 | |
| 26,144,000 | |
| 25,016,000 | |
| 24,806,000 | |
| 21,358,000 | |
| 20,383,000 | |
| 18,845,000 | |
| 20,102,000 | |
| 20,718,000 | |
| 20,749,000 | |
| 21,676,000 | |
| 21,857,000 | |
| 20,725,000 | |
| 20,601,000 | |
| 20,849,000 | |
| 21,775,000 | |
| 21,557,000 | |
| 21,362,000 | |
| 12,707,000 | |
| 6,675,000 | |
| 6,621,000 | |
| 6,592,000 | |
| 5,520,000 | |
| 7,843,000 | |
| 3,046,000 | |
| 1,732,000 | |
| 1,630,000 | |
| 1,674,000 | |
| 2,027,000 | |
| 1,679,000 | |
| 1,692,000 | |
| 1,884,000 | |
| 1,780,000 | |
| 1,707,000 | |
| 1,670,000 | |
| 4,378,000 | |
| 1,343,000 | |
| 741,000 | |
| 671,000 | |
| 611,000 | |
| 688,000 | |
| 429,000 | |
| 270,000 | |
| 220,000 | |
| 217,000 | |
| 214,000 | |
| 227,000 | |
| 241,000 | |
| 233,000 | |
| 227,000 | |
| 216,000 | |
| 200,000 | |
| 164,000 | |
| 162,000 | |
| 221,000 | |
| 212,000 | |
| 213,000 | |
| 225,000 | |
| 228,000 | |
| 224,000 | |
| 219,000 | |
| 208,000 | |
| 298,352 | |
| 282,403 |